(NASDAQ:AMCI), LAS VEGAS, Jan. 09, 2026 (GLOBE NEWSWIRE) — AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), a leading AI-driven robotics solutions company, today announced its participation at CES(R) 2026. The Company demonstrated its latest artificial intelligence-powered technologies, headlined by Kyro(TM), its proprietary quadruped robotic platform. The demonstration comes at a pivotal time […]

(NASDAQ:EDBL),(NASDAQ:EDBLW), BELVIDERE, NJ, Jan. 09, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that Matthew McConnell, a member of the Company's Board of Directors, has joined Edible Garden's senior leadership

(TSX-V:SAGA),(Boerse Frankfurt – Freiverkehr:20H),(OTC US:SAGMF),(Other OTC:SAGMF), Best-to-date titanium-vanadium-iron drill results at Trapper Zone underscore Radar's large-scale oxide system within the 160 km(2) Dykes River intrusive complex near tidewater in Labrador VANCOUVER, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“SAGA” or the “Company”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American

(NYSE MKT:INDO), Company to present at upcoming DealFlow Discovery Conference on January 28 JAKARTA, INDONESIA AND DANVILLE, CA, Jan. 09, 2026 (GLOBE NEWSWIRE) — Indonesia Energy Corporation (NYSE American: INDO) (“IEC”), an oil and gas exploration and production company focused on Indonesia, today announced pre-drilling progress on its planned next two (2) wells at IEC's

GRIN Therapeutics, Inc., a leader in the development of targeted disease-specific therapies for serious neurodevelopmental disorders, today announced that it has dosed the first patient in its global Phase 3 Beeline trial of investigational radiprodil in individuals with GRIN-related neurodevelopmental disorder (GRIN-NDD) with gain-of-function variants (ClinicalTrials.gov identifier: NCT07224581). Radiprodil is a selective negative allosteric modulator

Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise, today announced the significant expansion of its gene therapy platform. Through an AI-driven expansion of its capsid design program and the addition of a new Innovation Platform, Avista will address critical barriers in AAV capsid engineering, large gene delivery,

LSF12 Helix Parent, LLC (“Parent”), an affiliate of certain investment funds managed by affiliates of Lone Star Funds (“Lone Star”), announced that it has commenced offers (the “Change of Control Offers”) to purchase any and all of the 6.2500% Senior Notes due 2029 (CUSIP No. 431571AF5) (the “2029 Notes”) and the 3.7500% Senior Notes due

Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies GlobeNewswire January 09, 2026 Phase 3 SELVA study evaluating QTORIN(TM) rapamycin 3.9% anhydrous gel (QTORIN(TM) rapamycin) for microcystic lymphatic malformations (microcystic LMs) remains on track, with

AMC Robotics Showcases Kyro(TM) at CES 2026, Embodying the “ChatGPT Moment for Physical AI” GlobeNewswire January 09, 2026 LAS VEGAS, Jan. 09, 2026 (GLOBE NEWSWIRE) — AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), a leading AI-driven robotics solutions company, today announced its participation at CES(R) 2026. The Company demonstrated its latest artificial

Edible Garden Appoints Board Member Matthew McConnell as Executive Vice President, Strategic Partnerships Seasoned Capital Markets and Financial Executive to Drive Strategic Growth and Market Expansion GlobeNewswire January 09, 2026 BELVIDERE, NJ, Jan. 09, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled